ReNeuron Announces New Data Concerning its ReNcell® Neural Stem Cell Lines
Guildford, UK, 31 May 2007: ReNeuron Group plc (LSE: RENE.L) today announces new data concerning its ReNcell®CX and ReNcell®VM neural cell lines. These cell lines are marketed through Millipore Corporation as drug discovery tools for academic and commercial research.